• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T180
Device Problem Low impedance (2285)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/13/2007
Event Type  malfunction  
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
Boston scientific received information that this implantable cardioverter defibrillator (icd) recorded shock impedance measurements of less than 20 ohms exhibited by these large epicardial patch leads.Defibrillation threshold (dft) testing was undertaken and a 31 joule and 41 joule shock resulted in shock impedance measurements of less than 20 ohms.The patch leads appeared fine under fluoroscopy.Technical services advised preserving device memory to a disk and returning for analysis to further troubleshoot.A copy of device memory was returned and forwarded for engineering analysis.Analysis of device memory determined that the exact shock impedance measurements were 18 ohms and that this measurement is acceptable for this device and leads.Engineering advised it would be appropriate to leave these items implanted and suggested monitoring to ensure that the system continues to function appropriately.No adverse patient effects were reported.The device was later explanted and returned for analysis 9 years later.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6019193
MDR Text Key57058373
Report Number2124215-2016-11166
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup
Report Date 07/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/26/2008
Device Model NumberT180
Other Device ID NumberVITALITY DR HE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/05/2016
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received07/25/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/30/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0068; 0185; 4470; 4968; T180
Patient Age68 YR
-
-